AMGEN INC — Director's Dealing 2012

Jul 31, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-07-27

Reporting Person: MCNAMEE BRIAN M (SVP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-27	Common Stock	M	1391	$71.88	Acquired	54680	Direct
2012-07-27	Common Stock	M	42109	$71.88	Acquired	96789	Direct
2012-07-27	Common Stock	M	1598	$62.55	Acquired	98387	Direct
2012-07-27	Common Stock	M	10000	$42.13	Acquired	108387	Direct
2012-07-27	Common Stock	M	10000	$50.44	Acquired	118387	Direct
2012-07-27	Common Stock	M	20000	$58.43	Acquired	138387	Direct
2012-07-27	Common Stock	S	85098	$82.739	Disposed	53289	Direct
2012-07-27	Common Stock	S	500	$81.872	Disposed	52789	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-27	Iso (Right to Buy)	$71.88	M	1391	Disposed	2013-04-03	Common Stock (1391)	Direct
2012-07-27	Nqso (Right to Buy)	$71.88	M	42109	Disposed	2013-04-03	Common Stock (42109)	Direct
2012-07-27	Iso (Right to Buy)	$62.55	M	1598	Disposed	2014-04-26	Common Stock (1598)	Direct
2012-07-27	Nqso (Right to Buy)	$42.13	M	10000	Disposed	2015-04-29	Common Stock (10000)	Direct
2012-07-27	Nqso (Right to Buy)	$50.44	M	10000	Disposed	2016-04-28	Common Stock (10000)	Direct
2012-07-27	Nqso (Right to Buy)	$58.43	M	20000	Disposed	2020-04-26	Common Stock (20000)	Direct

Footnotes

F1: The price reported is an average price. The prices ranged from $82.60 to $82.88 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.

F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3: These shares include 23 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.